Scientists and Education

Speaking at a Ciba Foundation symposium in London some years ago, Alvin Weinberg talked of the dangers that can arise when a highly technical issue such as nuclear reactor safety is subject to frenetic public debate. "There develops an escalation of contingency," the then-director of Oak Ridge National Laboratory said. "Each unlikely event connected with a reactor, once it becomes a matter of public discussion, seems to acquire a plausibility that goes much beyond what was originally intended. I

Written byBernard Dixon
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Speaking at a Ciba Foundation symposium in London some years ago, Alvin Weinberg talked of the dangers that can arise when a highly technical issue such as nuclear reactor safety is subject to frenetic public debate. "There develops an escalation of contingency," the then-director of Oak Ridge National Laboratory said. "Each unlikely event connected with a reactor, once it becomes a matter of public discussion, seems to acquire a plausibility that goes much beyond what was originally intended. In consequence, re actors now, at least in the U.S.A., are loaded down with safety system after safety system. The safety and emergency systems dominate the whole technology."

Many scientists would have backed up these remarks with strong words about the damaging effect of public antipathy on the vigorous development of science and technology. Weinberg did not. Instead, he went out of his way to extol the American climate of open debate ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies